A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors
Matthew G. Fury, Allan Lipton, Katherine M. Smith, Corinne B. Winston, David G. Pfister
Dive into the research topics of 'A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors'. Together they form a unique fingerprint.